Member Info for druml

Get your glasses and read what I said.

Don't keep being a numpty

It is good that we are having a serious discussion on this matter.

My view would be that £100m is way too low for the assets we have.

I recon £2 per share would be very cheap for a pharma.

In a biding war £5 possible.

I am sure there will be approaches this summer.

Good luck to us all and hang on in there.

I do not think the market is going to reflect the value of fusion any time soon.

It would be best for us all if it was acquired by a US biotech or pharma.

I suspect it will happen inside 12 months.

Just hold on and wait for payday. The local tampers and derampers will make no difference.

We know we have some great assets that have substantial value. The UK market just does not seem to see it.

Why would someone be a big seller with this news?

Just not on a lot of investors radar.

That is why I agree it is likely to be acquired in the next year.

Yes they will have spent a lot of money getting to phase 2 and then stoping so they have a motivation to look at the fusion one.

Given the AZ Mou they may be in prime position. But it will be all about the deal £££££££££

BOOM

great update everyone was looking for.

Progress is significantly ahead of early expectations.

It is important that the formal agreement in place with QUB.

Now the important commercial bit of landing a £b deal.

Roche,GSK and Az must be talking to them already.

Exciting news.

Hold on tight

Agreed

Very well put.

I think the problem is the chairman has always been anti comuication

Great research

Thank you

We know the company are close to Roche.

I believe they helped re engineer herceptin and then rick in named on the patent.

It would make sense that they are working on optimal as well.

There is a lot happening under the radar.

Hope it is rns soon

Someone knows something looking at the big buys!!

He should be getting a board position.

Would really help the top team

Hope is stays at these prices until new tax year.

Then loading ISA again

Anyone else thinking the same?

Be rude not to buy some more.

Been in for the penny looking for the £££

Prudent decision by the board. Give the headroom for getting the deals in.

Good to see director support.

Living in lala land

On the Christmas sauce too early !!

The fact that nih are involved in the optimal deal is significantly important.

This can open up the other us institutions such as centre of disease control. CDC and other.

Fusion has a track record of working with these bodies in the past.

We can also be assured that Roche are talking to Fusion as there is a long positive relationship there.

These will all bear fruit in 2026.

Agreed

They need to start winning contracts and generating the cash before any rebate.

There are a lot of fantasy shareholders here.

Don't be blinded by science.

We need the commercial side now.

I am sure they will deliver before cash runs out.

Let's all just be realistic

I really think the holding of institutions and long term pi s is well in excess of 25m shares. Maybe double

Do you ever get the feeling with this continues selling that someone or group have information .

This happen before the last placing!

Strange the ongoing selling. Must be a big holder

The team have done well and delivered as promised.

It must however be recognised that the cash position is weak. It is unlikely they can strike the big deals the technology van deliver without a better cash position.

It would not be unreasonable to go for a further cash raise in the new year after the optimal launch.

I would support it.